Why the study?
Does the use of fixed-dose combinations improve adherence and cardiovascular prognosis in patients with arterial hypertension?
Does the use of fixed-dose combinations improve adherence and cardiovascular prognosis in patients with arterial hypertension?
Fixed-dose combinations are highlighted as a key strategy to improve medication adherence and cardiovascular outcomes in patients with arterial hypertension.
Supports fixed-dose combinations for adherence in hypertension; leaves open confirmation of CV outcome benefits in prospective trials.
Cardiovascular diseases occupy one of the leading places in the structure of morbidity, mortality and disability of the population. Arterial hypertension (AH) is the major risk factor for the development of cardiovascular diseases. The problem of insufficient adherence to the treatment of AH remains unresolved in many countries. The administration of fixed combinations is a major way to increase adherence to antihypertensive therapy. In addition, the use of fixed combinations helps to improve the cardiovascular the prognosis in patients with AH by reducing the risk of developing cardiovascular complications.
No takes yet. Share an insight, caveat, or question.
Акатова et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: